Mechanism of Action and Clinical Attributes of Auryxia<sup>®</sup> (Ferric Citrate).
Ganz T, Bino A, Salusky IB.
Drugs · review-article; review; journal article · DOI 10.1007/s40265-019-01125-w PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för iron(III) citrate. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
9 hitsFerric citrate controls phosphorus and delivers iron in patients on dialysis.
Lewis JB, Sika M, Koury MJ, Chuang P, Schulman G, Smith MT, Whittier FC, Linfert DR, Galphin CM, Athreya BP, Nossuli AK, Chang IJ, Blumenthal SS, Manley J, Zeig S, Kant KS, Olivero JJ, Greene T, Dwyer JP, Collaborative Study Group.
J Am Soc Nephrol · clinical trial, phase iii; research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1681/asn.2014020212Effect of oral JTT-751 (ferric citrate) on hyperphosphatemia in hemodialysis patients: results of a randomized, double-blind, placebo-controlled trial.
Yokoyama K, Hirakata H, Akiba T, Sawada K, Kumagai Y.
Am J Nephrol · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1159/000344008The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients.
Sinsakul M, Sika M, Koury M, Shapiro W, Greene T, Dwyer J, Smith M, Korbet S, Lewis J, Collaborative Study Group.
Nephron Clin Pract · clinical trial, phase ii; research support, non-u.s. gov't; journal article · DOI 10.1159/000341922Iron availability increases the pathogenic potential of Salmonella typhimurium and other enteric pathogens at the intestinal epithelial interface.
Kortman GA, Boleij A, Swinkels DW, Tjalsma H.
PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0029968Mechanism and kinetics of ligand exchange between ferric citrate and desferrioxamine B.
Ito H, Fujii M, Masago Y, Yoshimura C, Waite TD, Omura T.
J Phys Chem A · research support, non-u.s. gov't; journal article · DOI 10.1021/jp202440eIron(III) citrate speciation in aqueous solution.
Silva AM, Kong X, Parkin MC, Cammack R, Hider RC.
Dalton Trans · research support, non-u.s. gov't; journal article · DOI 10.1039/b910970fIron (III) citrate inhibits polyethylenimine-mediated transient transfection of Chinese hamster ovary cells in serum-free medium.
Eberhardy SR, Radzniak L, Liu Z.
Cytotechnology · research-article; journal article · DOI 10.1007/s10616-009-9198-8Structural basis of gating by the outer membrane transporter FecA.
Ferguson AD, Chakraborty R, Smith BS, Esser L, van der Helm D, Deisenhofer J.
Science · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1126/science.1067313